• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan.日本针对老年人的优先接种疫苗对新冠疫情的影响。
Glob Health Med. 2022 Apr 30;4(2):129-132. doi: 10.35772/ghm.2022.01015.
2
The number of COVID-19 clusters in healthcare and elderly care facilities averted by vaccination of healthcare workers in Japan, February-June 2021.2021 年 2 月至 6 月,日本为医护人员接种疫苗,避免了医疗机构和养老院中出现 COVID-19 聚集性病例。
Math Biosci Eng. 2022 Jan 12;19(3):2762-2773. doi: 10.3934/mbe.2022126.
3
Economic Value of Vaccines to Address the COVID-19 Pandemic in Hong Kong: A Cost-Effectiveness Analysis.疫苗对香港应对2019冠状病毒病大流行的经济价值:一项成本效益分析。
Vaccines (Basel). 2022 Mar 23;10(4):495. doi: 10.3390/vaccines10040495.
4
Navigating Japan's COVID-19 Vaccination Challenges: A Shift in Legal Classification and the Opt-out System.应对日本新冠疫苗接种挑战:法律分类的转变与退出机制
JMA J. 2024 Jan 15;7(1):106-108. doi: 10.31662/jmaj.2023-0061. Epub 2023 Nov 27.
5
Japan's healthcare policy for the elderly through the concepts of self-help (Ji-jo), mutual aid (Go-jo), social solidarity care (Kyo-jo), and governmental care (Ko-jo).日本的老年人医疗保健政策通过自助 (Ji-jo)、互助 (Go-jo)、社会团结关怀 (Kyo-jo) 和政府关怀 (Ko-jo) 的理念。
Biosci Trends. 2018 Mar 18;12(1):7-11. doi: 10.5582/bst.2017.01271. Epub 2018 Feb 26.
6
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
7
The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan.新冠疫情增加了日本对肺炎球菌疫苗接种的需求。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4673-4674. doi: 10.1080/21645515.2021.1958612. Epub 2021 Aug 6.
8
Routine childhood vaccination rates in an academic family health team before and during the first wave of the COVID-19 pandemic: a pre-post analysis of a retrospective chart review.在 COVID-19 大流行第一波期间和之前,学术型家庭健康团队中儿童常规疫苗接种率:回顾性图表审查的前后分析。
CMAJ Open. 2022 Jan 25;10(1):E43-E49. doi: 10.9778/cmajo.20210084. Print 2022 Jan-Mar.
9
Challenge to improve Japan's deplorable HPV vaccination rate by local government actions.地方政府采取行动,努力提高日本令人堪忧的人乳头瘤病毒(HPV)疫苗接种率。
J Obstet Gynaecol Res. 2022 May;48(5):1233-1239. doi: 10.1111/jog.15202. Epub 2022 Mar 10.
10
COVID-19 and Long-Term Care Policy for Older People in Japan.日本的 COVID-19 和老年人长期护理政策。
J Aging Soc Policy. 2021 Jul-Oct;33(4-5):444-458. doi: 10.1080/08959420.2021.1924342. Epub 2021 May 14.

引用本文的文献

1
Achilles' heel: elderly COVID-19 vaccination policy in China.阿喀琉斯之踵:中国老年人的 COVID-19 疫苗接种政策。
Health Res Policy Syst. 2024 Aug 5;22(1):90. doi: 10.1186/s12961-024-01155-1.
2
Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease.老年人的结核病和 COVID-19:导致疾病负担加重的因素。
Front Immunol. 2023 Sep 27;14:1250198. doi: 10.3389/fimmu.2023.1250198. eCollection 2023.
3
Effectiveness of BNT162b2 Against Infection, Symptomatic Infection, and Hospitalization Among Older Adults Aged ≥65 Years During the Delta Variant Predominance in Japan: The VENUS Study.BNT162b2 疫苗在日本德尔塔变异株流行期间对≥65 岁老年人的感染、有症状感染和住院的有效性:VENUS 研究。
J Epidemiol. 2024 Jun 5;34(6):278-285. doi: 10.2188/jea.JE20230106. Epub 2024 Jan 31.
4
Presenteeism in front-line physicians involved in COVID-19-related clinical practice: a national survey of employed physician members of the Japan Medical Association.参与 COVID-19 相关临床实践的一线医师的出勤主义:对日本医师协会就业医师会员的全国性调查。
Environ Health Prev Med. 2023;28:13. doi: 10.1265/ehpm.22-00194.
5
Impact of the COVID-19 pandemic on racial and ethnic minorities in Japan.COVID-19 疫情对日本少数族裔的影响。
Epidemiol Infect. 2022 Oct 26;150:e202. doi: 10.1017/S0950268822001674.

本文引用的文献

1
Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan.日本不同年龄组住院老年 COVID-19 患者中合并症作为重症疾病的危险因素。
Gerontology. 2022;68(9):1027-1037. doi: 10.1159/000521000. Epub 2022 Jan 7.
2
The strategy behind Japan's response to COVID-19 from 2020-2021 and future challenges posed by the uncertainty of the Omicron variant in 2022.2020 至 2021 年日本应对 COVID-19 的策略,以及 2022 年奥密克戎变异株不确定性带来的未来挑战。
Biosci Trends. 2022 Jan 23;15(6):350-352. doi: 10.5582/bst.2021.01560. Epub 2021 Dec 28.
3
Hospital capacity during the COVID-19 pandemic.新冠疫情期间的医院收治能力。
Glob Health Med. 2021 Apr 30;3(2):56-59. doi: 10.35772/ghm.2021.01031.
4
The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020.免疫实践咨询委员会更新的 COVID-19 疫苗分配临时建议-美国,2020 年 12 月。
MMWR Morb Mortal Wkly Rep. 2021 Jan 1;69(5152):1657-1660. doi: 10.15585/mmwr.mm695152e2.
5
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics.日本的第一波和第二波新冠疫情:疾病严重程度和特征的比较。
J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.10.033. Epub 2020 Nov 2.
6
Fairly Prioritizing Groups for Access to COVID-19 Vaccines.合理确定获得新冠疫苗的优先群体
JAMA. 2020 Oct 27;324(16):1601-1602. doi: 10.1001/jama.2020.18513.
7
Clusters of COVID-19 in long-term care hospitals and facilities in Japan from 16 January to 9 May 2020.2020 年 1 月 16 日至 5 月 9 日日本长期护理医院和设施中的 COVID-19 集群。
Geriatr Gerontol Int. 2020 Jul;20(7):715-719. doi: 10.1111/ggi.13973.

日本针对老年人的优先接种疫苗对新冠疫情的影响。

Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan.

作者信息

Nomoto Hidetoshi, Hayakawa Kayoko, Ohmagari Norio

机构信息

Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Miyagi, Japan.

出版信息

Glob Health Med. 2022 Apr 30;4(2):129-132. doi: 10.35772/ghm.2022.01015.

DOI:10.35772/ghm.2022.01015
PMID:35586768
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9066456/
Abstract

The Japanese government implemented a large-scale vaccination policy against the coronavirus disease 2019 (COVID-19) pandemic, primarily using messenger RNA vaccines in 2021. Its hallmark was prioritized vaccination for the elderly after healthcare workers in a short period of time. Vaccination for the elderly, vulnerable to infection and severe disease, was carried out rapidly in approximately 4 months since April 2021. We evaluated the impact of Japan's vaccination policy against COVID-19 during the pandemic, with a particular focus on how prioritized vaccination for the elderly affected the pandemic. We observed a remarkable decrease in the number of infections, cluster events in long-term care facilities, and severe disease among the elderly during the fifth wave (August 2021) despite rising incidence of infections in the overall population. In conclusion, we think that prioritized vaccination for the elderly was efficacious in preventing infections and severe COVID-19 among the elderly during the fifth wave in Japan.

摘要

日本政府针对2019冠状病毒病(COVID-19)大流行实施了大规模疫苗接种政策,2021年主要使用信使核糖核酸疫苗。其特点是在短时间内,在医护人员之后优先为老年人接种疫苗。自2021年4月起,在大约4个月的时间里迅速为易感染和易患重病的老年人进行了疫苗接种。我们评估了日本在大流行期间针对COVID-19的疫苗接种政策的影响,特别关注对老年人的优先接种如何影响了大流行。我们观察到,尽管总体人群中的感染率有所上升,但在第五波疫情(2021年8月)期间,感染人数、长期护理机构中的聚集性事件以及老年人中的重症病例显著减少。总之,我们认为在日本第五波疫情期间,对老年人的优先接种在预防老年人感染和重症COVID-19方面是有效的。